Floating Extended Release Tablets of Tenofovir Formulation and Design by Central Composite Design (CCD) Using Cetyl Alcohol as Floating Assistant

Indian Journal of Pharmaceutical Education and Research

  • Challa Taraka Ramarao1Department of Pharmaceutical Technology, Sri Venkateswara College of Pharmacy, Etchrela, Srikakulam, Andhra Pradesh, INDIA.
  • Siba Patri1Department of Pharmaceutical Technology, Sri Venkateswara College of Pharmacy, Etchrela, Srikakulam, Andhra Pradesh, INDIA.

Volume 60 Issue 3s Pages s1012-s1023

DOI: 10.5530/ijper.20262471

Abstract

Introduction: The Tenofovir (TFR) is a BCS Class III widely prescribed treatment of HIV and Hepatitis. Materials and Methods: The CCD was used to statistically optimization parameters and evaluate on the efficacy of gastro retentive floating behaviour. The concentration of HPMC K100 M (X1), Cetyl Alcohol (X2) and Ethyl Cellulose (X3) were selected independent variables. To determine the following: drug release kinetics, counter and 3D surface plots, in vitro dissolution and comparison of TenoHep with optimized and F1 Formulation, swelling-erosion index, floating attributes and tablet properties. Results: The formulation R2 was higher when fitted to zero order equation which indicates that a zero order release, except F12 as first order. Conclusion: The optimization floating is well suitable for gastro retentive following extend release.

Keywords

  • TenoHep
  • Tenofovir
  • Floating
  • Optimization
  • In vitro
IJOPP

Loading…